HSCSWHeartSciences Inc.同业对比
HeartSciences Inc. 与Orthopedic, Prosthetic & Surgical Appliances & Supplies的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Orthopedic, Prosthetic & Surgical Appliances & Supplies)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HSCSW本股 | $240599#16 | — | 1.1x#5 | 55.7x#12 | -0.7%#14 | -4.3%#8 | -194787.4%#15 | -4044.0%#16 | — | — | 95.3%#4 | — |
| ALGN | $12.6B#2 | 29.5x#2 | 3.0x#9 | 3.1x#8 | 0.9%#11 | -2.6%#7 | 13.5%#2 | 9.9%#3 | — | — | -14.7%#10 | — |
| APT | $51M#10 | 14.6x#1 | 0.8x#4 | 0.9x#4 | 2.3%#9 | -10.3%#9 | 6.5%#4 | 5.6%#4 | — | — | 3.7%#8 | — |
| AVNS | $1.2B#6 | — | 1.5x#7 | 1.7x#5 | 1.9%#10 | 81.4%#1 | -8.8%#7 | -9.3%#6 | -6.5%#4 | 4#3 | 110.2%#3 | — |
| AVR | $795M#7 | — | 2.9x#8 | 415.7x#14 | -29.2%#15 | -23.4%#12 | -4908.2%#11 | -33.8%#7 | — | — | 155.7%#1 | — |
| BBLG | $2M#15 | — | 0.4x#2 | 0.0x#1 | 0.0%#12 | 24.4%#4 | -0.3%#5 | -66.6%#8 | — | — | -62.8%#12 | — |
| BBLGW | $16M#12 | — | 3.4x#10 | 0.0x#2 | 0.0%#12 | 24.4%#4 | -0.3%#5 | -66.6%#8 | — | — | -88.9%#14 | — |
| CDRE | $1.4B#5 | 39.8x#3 | 4.3x#11 | 2.3x#7 | 7.5%#5 | 22.2%#6 | 11.0%#3 | 13.1%#1 | 7.2%#2 | 4#3 | 1.1%#9 | 1.1%#3 |
| CLGN | $4M#13 | — | 0.7x#3 | 1.7x#6 | 360.4%#1 | 30.8%#3 | -484.3%#10 | -188.9%#12 | 0.0%#3 | 3#7 | -87.1%#13 | — |
| CNXU | $206M#8 | — | 28.6x#15 | — | — | — | — | 0.0%#5 | — | — | — | — |
| COCH | $52M#9 | — | 5.1x#13 | 215.2x#13 | 7.1%#6 | -14.2%#10 | -9240.7%#12 | -233.8%#13 | — | — | -56.1%#11 | 3.5%#2 |
| COCHW | $4M#14 | — | 0.4x#1 | 16.6x#11 | 7.1%#6 | -14.2%#10 | -9240.7%#12 | -233.8%#13 | — | — | 48.2%#5 | 45.6%#1 |
| CUPR | $27M#11 | — | 6.7x#14 | 683.5x#15 | 9.2%#4 | -216.7%#15 | -9680.1%#14 | -92.4%#11 | -229.7%#7 | 5#2 | -94.2%#15 | — |
| ENOV | $1.7B#4 | — | 1.2x#6 | 0.8x#3 | 6.7%#8 | -43.5%#13 | -50.0%#9 | -80.2%#10 | -40.6%#6 | 4#3 | 8.0%#6 | — |
| ESTA | $2.7B#3 | — | 183.0x#16 | 12.8x#10 | 27.1%#2 | 39.6%#2 | -18.5%#8 | -345.4%#15 | -19.0%#5 | 4#3 | 122.2%#2 | — |
| EW | $48.2B#1 | 44.5x#4 | 4.7x#12 | 7.9x#9 | 11.5%#3 | -74.3%#14 | 20.8%#1 | 10.4%#2 | 12.4%#1 | 6#1 | 3.9%#7 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-07-29。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议